Qsymia

152

also known as Qnexa is a FDA approved weight loss drug formulated from appetite suppressant drug phentermine and migraine drug topiramate. It is prescribed for individuals with BMI over 30 and Co-Morbid. FDA recommends Qsymia as an adjunct ( optional ) to a reduced-calorie diet and increased physical activity for chronic weight management.